Condition
Pilonidal Disease of Natal Cleft
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06286397Phase 2Recruiting
Topical Anti-Androgens in Pilonidal Sinus Disease
NCT06140199Not ApplicableNot Yet Recruiting
Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)
NCT05404243Phase 4Completed
Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease
NCT04430413Not ApplicableCompletedPrimary
Effect of Platelet Rich Plasma on Healing of Operated Pilonidal Sinus by Open Method
NCT03424057Not ApplicableCompleted
Asymmetric Primary Closure and Additional Skin Excision Technique.
Showing all 5 trials